Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
03/2005
03/03/2005WO2005019411A2 Ancestral viruses and vaccines
03/03/2005WO2005019259A2 Variants of interleukin-1 receptor antagonist: compositions and uses thereof
03/03/2005WO2005018657A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY
03/03/2005WO2005018650A2 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
03/03/2005WO2005018575A2 Estrogen receptor modulators and uses thereof
03/03/2005WO2005018571A2 Compositions and methods for treating inflammatory lung disease
03/03/2005WO2005018549A2 Methods and compositions for tissue repair
03/03/2005WO2005018537A2 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
03/03/2005WO2005018534A2 Methods and compositions for rna interference
03/03/2005WO2005018331A1 Neurogenin3 and production of pancreatic islet cells
03/03/2005WO2004104032A3 Methods and compositions related to high-titer pseudotyped retroviruses
03/03/2005WO2004098647A3 Claudins’ underexpression as markers of tumor metastasis
03/03/2005WO2004075835A3 Methods for the treatment of renal cell carcinoma
03/03/2005WO2004072269A9 Bex4 nucleic acids, polypeptides, and method of using
03/03/2005WO2004029212A3 In vivo gene silencing by chemically modified and stable sirna
03/03/2005WO2004001058A3 Transcription factor modulating compounds and methods of use thereof
03/03/2005WO2003102151A3 Modulating cell differentiation and treating myeloprolifertive disorders with jnk/mkk inhibitors
03/03/2005WO2003100006A3 Method of improved prostate cancer detection
03/03/2005WO2003099219A3 Bryostatins, bryopyrans and polyketides: compositions and methods
03/03/2005WO2003045317A3 Therapeutic protein and treatments
03/03/2005WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
03/03/2005WO2002074911A3 Identification of gene expression alterations underlying the aging process in mammals
03/03/2005US20050049408 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity; solid phase synthesis; kits
03/03/2005US20050049219 Methods of treatment with mini-dystrophin nucleic acid sequences
03/03/2005US20050049217 Stimulating the proliferation of kidney tubule epithelial cells in vivo using Zvegf4, a mitogenic multidomain protein with homology to the PDGF/VEGF family of growth factors; platelet-derived growth factor (PDGF); vascular endothelial growth factors (VEGF); renal failure
03/03/2005US20050049216 Immunostimulatory nucleic acid molecules
03/03/2005US20050049215 contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulating interferon-alpha to treat viral infections; oligonucleotide linked to a biodegradable delivery complex
03/03/2005US20050049214 Inhibition of E3-ubiquitin ligase HAKAI for treatment of proliferative disorders
03/03/2005US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides
03/03/2005US20050049211 Oligonucleotides for treating hyperproliferative diseases such as cancer, inflammatory, developmental or metabolic disorders
03/03/2005US20050049193 Leptin-related peptides
03/03/2005US20050049185 Gene encoding a multidrug-resistance human P-glycoprotein homologue on chromosome 7p15-2 and uses thereof
03/03/2005US20050049176 Treating a hypoproliferative cell disorder or disorder involving increased cell death in a patient by administering a therapeutically effective amount of an EphA2 antagonistic agent; treatment of Inflammatory Bowel Disease
03/03/2005US20050048639 Caspase-8 binding protein, its preparation and use
03/03/2005US20050048628 Immunological binding molecules inhibiting the syncytial fusion of trophoblast
03/03/2005US20050048605 Novel polypeptide dna thereof and use of the same
03/03/2005US20050048590 Streptococcal enolase for use in generating immunoglobulins for use in prevention and treatment of microorganismal infection; immunotherapy
03/03/2005US20050048584 Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof
03/03/2005US20050048560 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
03/03/2005US20050048557 Expression vector comprising nucleotide sequences coding microorganismsal protein for use in developing vaccine agents which prevent bacterial infection; bactericides; microbiocides
03/03/2005US20050048537 Novel human lipocalin homologs and polynucleotides encoding the same
03/03/2005US20050048525 Amino acid sequences having hydrolase enzyme activity for use diagnosis, prevention and treatment of cardiovascular and gastrointestinal disorders; drug screening; bioassay
03/03/2005US20050048511 Truncated glycogen synthase kinase 3 protein for use in identifying modulators to treat diabetes, inflammation and nervous system disorders; drug screening
03/03/2005US20050048507 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/03/2005US20050048491 Methods and kits for use in selecting approaches to treating cancer
03/03/2005US20050048476 Expression vector comprising tumor necrosis factor fusion for use in identifying modulator for treatment of cell proliferaive disorders; antitumor agents
03/03/2005US20050048466 Recombinant virus comprising virus proliferating essential gene (VPEG) for use in the treatment of cell proliferative disorders; cancer therapeutics
03/03/2005US20050048069 Methods and compositions for modulating immunity
03/03/2005US20050048068 Major histocompatibility complex epitopes; immunotherapy ; induce immunology response
03/03/2005US20050048061 Uses of mammalian cytokines and agonists; related reagents
03/03/2005US20050048043 Methods for in vivo gene transfer into pancreatic and biliary epithelial cells
03/03/2005US20050048042 Compositions and methods for the treatment of schizophrenia and addictive disorders
03/03/2005US20050048040 Antidiabetic agents; adjustment of endothelial cells
03/03/2005US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke
03/03/2005US20050048031 Defective recombinant adenoviruses expressing cytokines for antitumor treatment
03/03/2005US20050048030 Parainfluenza virus, respiratory syncytial virus infection genetic engineering vectors; heterologous nucleic acids
03/03/2005US20050048029 Nucleotide sequence for diagnosis, prevention, therapy of cancer, inflammation, autoimmune disease and infections
03/03/2005US20050048028 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage
03/03/2005CA2536946A1 Estrogen receptor modulators and uses thereof
03/03/2005CA2536654A1 Anti-cancer vaccines
03/03/2005CA2536495A1 Promoter of synoviolin gene
03/03/2005CA2536086A1 Inhibition of dr3 in the treatment of allergic lung inflammation
03/03/2005CA2535753A1 Neurogenin3 and production of pancreatic islet cells
03/03/2005CA2535745A1 Anti-bacterial composition, especially for controlling gram-negative bacteria, comprising a peptide and an advantageously hydrophobic anti-bacterial agent
03/03/2005CA2535585A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby
03/03/2005CA2534547A1 Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
03/03/2005CA2526853A1 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors
03/03/2005CA2525619A1 Methods and compositions for rna interference
03/02/2005EP1510224A1 In vivo gene transfer methods for wound healing
03/02/2005EP1509772A2 Diagnostics and therapeutics for diseases associated with neuromedin u2 receptor (nmu2)
03/02/2005EP1509768A2 Methods for cohort selection and longevity studies
03/02/2005EP1509621A1 Treatment with cytokines for alzheimer's disease
03/02/2005EP1509617A2 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue
03/02/2005EP1509607A1 Immunogenic sequences
03/02/2005EP1509253A1 Chimeric cd154
03/02/2005EP1509252A2 Methods and compositions for correction of cardiac conduction disturbances
03/02/2005EP1509251A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
03/02/2005EP1509250A1 Methods compositions and articles of manufacture for modulating bone growth
03/02/2005EP1509203A2 Delivery of nucleic acid-like compounds
03/02/2005EP1509086A2 Htlv-i tax induced killing of p53 null cancer cells
03/02/2005EP1421115B1 Soluble t cell receptor
03/02/2005EP1137764B1 New medical use of gene and vector encoding a multisubstrate deoxyribonucleosidase
03/02/2005EP1034291B1 Pseudo-type retroviral vectors with modified surface capsid proteins and method for the production thereof for selective gene transfer
03/02/2005EP0977881B1 Expression of a modified foamy virus envelope protein
03/02/2005EP0846181B1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS
03/02/2005EP0832271B8 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
03/02/2005EP0799311B1 Human chemokine beta-9
03/02/2005EP0682708B9 Antiviral composition of viral protein trans-dominant variants
03/02/2005CN1589330A Stem cells of the islets of langerhans and their use in treating diabetes
03/02/2005CN1587411A Preparation of KTV series products for inhibiting tumor cell growth and use
03/02/2005CN1587408A Structure of anti-hypatitis B virus antisense oligonucleotide of target de-sialoglycoprotein receptor
03/02/2005CN1587407A Si RNA capable of controlling foot-and-mouth disease virus copying and infection and its preparing method and use
03/02/2005CN1587406A SiRNA double chain for inhibiting bc 1-2 gen expression and use
03/02/2005CN1191357C Orally immunogenic bacterial enterotoxins expressed in transgenic plants
03/02/2005CN1191355C Process for preparing fowl paralysis virus using cntinuous avian cell line
03/02/2005CN1191094C Targeted liposome gene delivery
03/02/2005CN1191090C Use of enterobaterium protein ompA associated with antigen for generating antiviral, aniparsitic or antitumoral cytotoxic response
03/02/2005CN1191089C Use of an OmpA enterobacteriumprotein associated with the ELAGIGILTV peptide for treating melanomal
03/01/2005US6861509 Antibodies to Ret and RetL3
03/01/2005US6861506 Compositions and methods for the treatment and diagnosis of breast cancer
1 ... 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 ... 870